Hainan New Spring International Cell Therapy Hospital

Hainan Xinshengquan International Cell Therapy Hospital is located in Hainan Boao Lecheng International Medical Tourism Pilot Zone, covering an area of 25 mu (1.67 hectares) with a total investment of 465 million yuan. It is one of the first hospitals in China granted stem cell therapy qualification by the state. Affiliated with Shanghai Likun Biotechnology Co., Ltd. (established in April 2014), the hospital was co-founded by professors and doctors returning from Europe and the United States, led by experts from the "Thousand Talents Program." The hospital has built a clinical-grade cell preparation production base that complies with international cGMP/GCCP standards from China's NMPA, America's FDA, and the EU's EMA. Following the State Council's "pilot implementation" policy for stem cell translational medicine in the Hainan Pilot Zone (State Council Document [2013] No. 33), the hospital provides "one-stop" stem cell healthcare and medical services. With 18 clinical departments including internal medicine, oncology, plastic surgery, medical aesthetics, rehabilitation medicine, and geriatrics, the hospital has been approved for 100 beds. Dedicated to health management and biomedical technology research and application, the hospital provides personalized medical services. Upholding the principles of "safe and effective, scientific basis, compliance with laws and regulations, and customers first," the hospital creates a health management medical industrialization platform integrating recovery, treatment, and precision digital healthcare.